Table 3.
| ||||||
---|---|---|---|---|---|---|
Study (Reference) | Year | Country | Number of patients | Intervention in case group/area | Intervention in control group/areas | Evaluation method |
| ||||||
Mark et al. (55) | 2016 | Netherlands | 52 | Autologous buffy-coat PRP | SSG alone | POSAS, dermospectrometer, cutometer |
Elsayed et al. (54) | 2017 | Egypt | 38 | Autologous PRP | Silicone-based products | POSAS |
Ruiz et al. (53) | 2018 | Colombia | Case report | Autologous PRP | Vancouver and POSAS | |
Karakol and Bozkurt (40) | 2021 | Turkey | 29 | ROM, POSAS, histopathological | ||
|
PRP; Platelet rich plasma, POSAS; Patient and observer scar assessment scale, and ROM; Range of motion.